Recent Advances in Alcohol-related Liver Disease (ALD): Summary of a Gut Round Table Meeting

Overview

Journal Gut

Specialty Gastroenterology

Date 2019 Dec 28

PMID 31879281

Citations 73

Authors

Matias A Avila

Jean-Francois Dufour

Alexander L Gerbes

Fabien Zoulim

Ramon Bataller

Patrizia Burra

Helena Cortez-Pinto

Bin Gao

Ian Gilmore

Philippe Mathurin

Christophe Moreno

Vladimir Poznyak

Bernd Schnabl

Gyongyi Szabo

Maja Thiele

Mark R Thursz

Affiliations

Soon will be listed here.

Abstract

Alcohol-related liver disease (ALD), which includes a range of disorders of different severity and is one of the most prevalent types of liver disease worldwide, has recently regained increased attention. Among other reasons, the realisation that any alcohol intake, regardless of type of beverage represents a health risk, and the new therapeutic strategies tested in recently published or undergoing clinical trials spur scientific interest in this area.In April 2019, Gut convened a round table panel of experts during the European Association for the Study of the Liver International Liver Congress in Vienna to discuss critical and up-to-date issues and clinical trial data regarding ALD, its epidemiology, diagnosis, management, pathomechanisms, possible future treatments and prevention. This paper summarises the discussion and its conclusions.

Citing Articles

Evidence construction of Silibinin capsules against alcoholic liver disease based on a meta-analysis and systematic review.

Wang Y, Yang W, Yang Y, Liu X, Peng L, Huang Q Front Pharmacol. 2025; 16:1516204.

PMID: 39968181 PMC: 11832396. DOI: 10.3389/fphar.2025.1516204.

Immune cells in alcohol-related liver disease.

Xu H, Wang H Liver Res. 2025; 6(1):1-9.

PMID: 39959807 PMC: 11791833. DOI: 10.1016/j.livres.2022.01.001.

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk.

Granel N, Iserte G, Bartres C, Llarch N, Pla A, Sapena V BMC Gastroenterol. 2025; 25(1):51.

PMID: 39901067 PMC: 11792182. DOI: 10.1186/s12876-025-03611-w.

Research on the function of epigenetic regulation in the inflammation of non-alcoholic fatty liver disease.

Sun L, Yue Z, Wang L Life Med. 2025; 3(4):lnae030.

PMID: 39872862 PMC: 11749620. DOI: 10.1093/lifemedi/lnae030.

Hong X, Huang S, Jiang H, Ma Q, Qiu J, Luo Q Front Pharmacol. 2024; 15:1432480.

PMID: 39669199 PMC: 11635172. DOI: 10.3389/fphar.2024.1432480.

References

Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J . Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013; 144(7):1426-37, 1437.e1-9. DOI: 10.1053/j.gastro.2013.02.042. View

Engstler A, Aumiller T, Degen C, Durr M, Weiss E, Maier I . Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease. Gut. 2015; 65(9):1564-71. DOI: 10.1136/gutjnl-2014-308379. View

Cresci G, Bush K, Nagy L . Tributyrin supplementation protects mice from acute ethanol-induced gut injury. Alcohol Clin Exp Res. 2014; 38(6):1489-501. PMC: 4185400. DOI: 10.1111/acer.12428. View

Brandl K, Hartmann P, Jih L, Pizzo D, Argemi J, Ventura-Cots M . Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J Hepatol. 2018; 69(2):396-405. PMC: 6054564. DOI: 10.1016/j.jhep.2018.03.031. View

Varma V, Webb K, Mirza D . Liver transplantation for alcoholic liver disease. World J Gastroenterol. 2010; 16(35):4377-93. PMC: 2941060. DOI: 10.3748/wjg.v16.i35.4377. View

Louvet A, Thursz M, Kim D, Labreuche J, Atkinson S, Sidhu S . Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials. Gastroenterology. 2018; 155(2):458-468.e8. DOI: 10.1053/j.gastro.2018.05.011. View

Morgan T . Is Granulocyte Colony Stimulating Factor a New Treatment for Alcoholic Hepatitis?. Clin Gastroenterol Hepatol. 2018; 16(10):1564-1565. DOI: 10.1016/j.cgh.2018.06.013. View

Loomba R, Yang H, Su J, Brenner D, Barrett-Connor E, Iloeje U . Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol. 2013; 177(4):333-42. PMC: 3626057. DOI: 10.1093/aje/kws252. View

Thursz M, Richardson P, Allison M, Austin A, Bowers M, Day C . Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015; 372(17):1619-28. DOI: 10.1056/NEJMoa1412278. View

10.

Gao B, Xu M, Bertola A, Wang H, Zhou Z, Liangpunsakul S . Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance. Gene Expr. 2017; 17(3):173-186. PMC: 5500917. DOI: 10.3727/105221617X695519. View

11.

Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F . Early liver transplantation for severe alcoholic hepatitis. N Engl J Med. 2011; 365(19):1790-800. DOI: 10.1056/NEJMoa1105703. View

12.

Ambade A, Lowe P, Kodys K, Catalano D, Gyongyosi B, Cho Y . Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice. Hepatology. 2018; 69(3):1105-1121. PMC: 6393202. DOI: 10.1002/hep.30249. View

13.

Michelena J, Altamirano J, Abraldes J, Affo S, Morales-Ibanez O, Sancho-Bru P . Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis. Hepatology. 2015; 62(3):762-72. PMC: 4549175. DOI: 10.1002/hep.27779. View

14.

Iracheta-Vellve A, Petrasek J, Gyogyosi B, Bala S, Csak T, Kodys K . Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice. Liver Int. 2017; 37(7):968-973. PMC: 5479767. DOI: 10.1111/liv.13430. View

15.

Wang W, Xu M, Cai Y, Zhou Z, Cao H, Mukhopadhyay P . Inflammation is independent of steatosis in a murine model of steatohepatitis. Hepatology. 2017; 66(1):108-123. PMC: 5481491. DOI: 10.1002/hep.29129. View

16.

Xu M, Cai Y, Wang H, Altamirano J, Chang B, Bertola A . Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans. Gastroenterology. 2015; 149(4):1030-41.e6. PMC: 4584194. DOI: 10.1053/j.gastro.2015.06.009. View

17.

Carvalho A, Heilig M, Perez A, Probst C, Rehm J . Alcohol use disorders. Lancet. 2019; 394(10200):781-792. DOI: 10.1016/S0140-6736(19)31775-1. View

18.

Katikireddi S, Whitley E, Lewsey J, Gray L, Leyland A . Socioeconomic status as an effect modifier of alcohol consumption and harm: analysis of linked cohort data. Lancet Public Health. 2017; 2(6):e267-e276. PMC: 5463030. DOI: 10.1016/S2468-2667(17)30078-6. View

19.

Bradley K, DeBenedetti A, Volk R, Williams E, Frank D, Kivlahan D . AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007; 31(7):1208-17. DOI: 10.1111/j.1530-0277.2007.00403.x. View

20.

Singh V, Sharma A, Narasimhan R, Bhalla A, Sharma N, Sharma R . Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study. Am J Gastroenterol. 2014; 109(9):1417-23. DOI: 10.1038/ajg.2014.154. View